HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

452.224

-3.631-0.80%

Number of Gainers:20

Number of Losers:28

Number of Flat:3

PE:- -

High:458.741

Open:455.974

Low:450.554

Close:455.854

Volume:299.99M

Turnover:6.35B

Market Cap:2.88T

Float Cap:1.99T

Loading ...

Ming Yuan Cloud Files HKEX Next-Day Return Disclosing Share Buyback Cancellation at HKD 3.12 Each

AK MEDICAL Ltd (01789) Expends HK$245,750 on Share Buyback on September 11

AK Medical Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

ZYLOXTB Repurchases 55,000 Shares for HK$1.12 Million on September 11

Hansoh Pharmaceutical Says Risvutatug Rezetecan Injection Included in NMPA Priority Review

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback for Cancellation

Xinyi Energy Files HKEX Next-Day Disclosure Return Disclosing Share Repurchase for Cancellation

Shandong Boan Biotech Files HKEX Next-Day Disclosure Reporting Share Repurchase for Treasury Shares

Venus Medtech Schedules Extraordinary General Meeting

Sunac Services Files HKEX Next-Day Disclosure Return After Share Buyback for Cancellation

LifeTech Swings to RMB 34.28 Million Net Loss in 1H FY26; Revenue Drops 11.2% to RMB 600.83 Million

Hong Kong Stocks Fall as Oil Extends Rally; Venus Medtech Gains

MT Newswires Live

Daiwa Cuts HAIDILAO Target Price to HK$11.3, Maintains Outperform Rating

Hansoh Pharma's Investigational Therapy for Small Cell Lung Cancer Granted Priority Review by Chinese Regulator

China Resources Beer (Holdings) Stock Slips 1.8% in Hong Kong

Haidilao International Holding Stock Rallies 1.5% in Hong Kong

Hansoh Pharmaceutical Group Stock Slides 1.9% in Hong Kong

Hansoh Pharma Says NMPA Grants Priority Review for HS-20093 in Small Cell Lung Cancer

Hansoh Pharmaceutical - Risvutatug Rezetecan for Injection Included in Nmpa Priority Review for Small Cell Lung Cancer

THOMSON REUTERS

MEDCAPTAIN's Hong Kong IPO: A Medical Device Empire Built on Acquisitions Faces Multiple Headwinds

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1583/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":452.22354,"timestamp":1789546124622,"preClose":455.85437,"halted":0,"volume":299993995,"delay":0,"changeRate":-0.007965,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-3.630829,"latestTime":"09-16 16:00:00","open":455.97388,"high":458.74115,"low":450.55423,"amount":6350408240.5,"amplitude":0.01796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":2.069963,"peRate":43.726837,"turnoverRate":0.002722,"increases":19,"decrements":29,"flats":1,"marketCap":2875189263312,"floatMarketCap":1990396956112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":458.74115,"amplitude":0.01796,"preClose":455.85437,"low":450.55423,"pbRate":"2.069963","latestPrice":452.22354,"volume":299993995,"delay":0,"open":455.97388,"prevYearClose":503.90085,"prevWeekClose":450.903,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":466.322,"twentyDayClose":485.91,"sixtyDayClose":397.333,"secType":"PLATE","market":"HK","turnoverRate":0.002722,"peRate":43.726837,"marketCap":2875189263312,"floatMarketCap":1990396956112,"timestamp":1789546124622,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":20,"down":28,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666262035","title":"Ming Yuan Cloud Files HKEX Next-Day Return Disclosing Share Buyback Cancellation at HKD 3.12 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666262035","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666262035?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:54","pubTimestamp":1789124049,"startTime":"0","endTime":"0","summary":"Ming Yuan Cloud files HKEX next-day return disclosing share buyback cancellation at HKD 3.12 eachMing Yuan Cloud filed a next-day disclosure return showing 1,000,000 shares repurchased on Sept. 11 at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDLbj5fl5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1109","BK1583","BK1518","00909","BK1117","BK1618","BK1607","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101229402","title":"AK MEDICAL Ltd (01789) Expends HK$245,750 on Share Buyback on September 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1101229402","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101229402?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:37","pubTimestamp":1789123040,"startTime":"0","endTime":"0","summary":"On September 11, 2026, AK MEDICAL (01789) allocated a total of HK$245,750 to repurchase 50,000 of its own shares.This buyback transaction reflects the company's ongoing capital management strategy,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1617","BK1583","BK1100","01789"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666526323","title":"AK Medical Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666526323","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666526323?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:34","pubTimestamp":1789122840,"startTime":"0","endTime":"0","summary":"AK Medical files HKEX next-day disclosure return on share repurchase for cancellationAK Medical repurchased 50,000 ordinary shares on Sept. 11, 2026, holding them as treasury shares.Buyback price HKD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL2FFVf5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","BK1617","BK1585","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139773299","title":"ZYLOXTB Repurchases 55,000 Shares for HK$1.12 Million on September 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1139773299","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139773299?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:21","pubTimestamp":1789122076,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced that on September 11, 2026, the company spent HK$1.1175 million to repurchase 55,000 shares.The buyback reflects the company's ongoing commitment to enhancing shareholder...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1587","BK1100","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666618525","title":"Hansoh Pharmaceutical Says Risvutatug Rezetecan Injection Included in NMPA Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2666618525","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666618525?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:18","pubTimestamp":1789121892,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Says Risvutatug Rezetecan Injection Included In NMPA Priority ReviewSept 11 (Reuters)-Hansoh Pharmaceutical Group Company Limited3692.HK:RISVUTATUG REZETECAN FOR INJECTION INCLUDED IN NMPA PRIORITY REVIEW FOR SMALL CELL LUNG CANCERFurther company coverage:3692.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45214K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525687","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Buyback for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525687","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525687?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:15","pubTimestamp":1789121750,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share buyback for cancellationZylox-Tonbridge filed a next-day disclosure return reporting a repurchase of 55,000 H shares on Sept. 11, 2026.Sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDLc8wFMJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1587","02190","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253075","title":"Xinyi Energy Files HKEX Next-Day Disclosure Return Disclosing Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253075","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253075?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:13","pubTimestamp":1789121593,"startTime":"0","endTime":"0","summary":"Xinyi Energy files HKEX next-day disclosure return disclosing share repurchase for cancellationXinyi Energy filed a next-day disclosure return showing 4,048,000 shares repurchased for cancellation on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL1XQcpp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BK1154","BK1594","BK1169","BK1583","BK1554","00968","03868","BK1589","LU1983299162.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666523224","title":"Shandong Boan Biotech Files HKEX Next-Day Disclosure Reporting Share Repurchase for Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666523224","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666523224?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:01","pubTimestamp":1789120909,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotech files HKEX next-day disclosure reporting share repurchase for treasury sharesShandong Boan Biotechnology filed an HKEX next-day disclosure return showing a repurchase of 500,000 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL12XpPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK1606","BK1191","BK1161","BK1583","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666239645","title":"Venus Medtech Schedules Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666239645","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666239645?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:54","pubTimestamp":1789120484,"startTime":"0","endTime":"0","summary":"Venus Medtech schedules extraordinary general meetingVenus Medtech will hold an extraordinary general meeting in Hangzhou on Sept. 30, 2026.Shareholders will vote on a proposed subscription of new sha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL8N4pJq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666528267","title":"Sunac Services Files HKEX Next-Day Disclosure Return After Share Buyback for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666528267","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666528267?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:40","pubTimestamp":1789119624,"startTime":"0","endTime":"0","summary":"Sunac Services files HKEX next-day disclosure return after share buyback for cancellationSunac Services filed a next-day disclosure return showing a 300,000-share on-market buyback on Sept. 11.Total r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL7cDXmf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01516","BK1229","BK1542","BK1258","BK1585","01918","BK1555","BK1521","BK1240"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547328","title":"LifeTech Swings to RMB 34.28 Million Net Loss in 1H FY26; Revenue Drops 11.2% to RMB 600.83 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547328","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666547328?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:38","pubTimestamp":1789115927,"startTime":"0","endTime":"0","summary":"LifeTech swings to RMB 34.28 million net loss in 1H FY26; revenue drops 11.2% to RMB 600.83 millionLifeTech Scientific posted revenue of RMB 600.83 million, down 11.2% from the year-ago period.Operati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9x8MK7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1583","BK1100","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666473665","title":"Hong Kong Stocks Fall as Oil Extends Rally; Venus Medtech Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2666473665","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666473665?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:36","pubTimestamp":1789115807,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed lower Friday as surging oil prices stoked inflation concerns.The Hang Seng Index fell 148.84 points, or 0.6%, to close at 24,805.63, while the Hang Seng China Enterprises Index lost 28.45 points, or 0.3%, to finish at 8,246.33.Brent crude rose as much as 6% to $109.97 a barrel, its highest in four months, and was on track for an 11% weekly gain as fighting between the U.S. and Iran disrupted oil flows through the Strait of Hormuz.Investors awaited U.S. August inflation data for further clues on the Fed's policy path, with core CPI forecast to rise 0.2% month-over-month.Higher oil prices and sticky inflation have also prompted JPMorgan to expect eight of nine developed-market central banks to raise rates by year-end.In corporate news, Venus Medtech  closed 5% higher after agreeing to subscribe for 500 million yuan of shares and convertible bonds.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","03037","07500","03115","02500","BK1574","82800","09115","02833","HHImain","BK1100","83115","MHImain","513600","HSTECH","HSI","07300","02800","MCHmain","07200","03419"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107281248","title":"Daiwa Cuts HAIDILAO Target Price to HK$11.3, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1107281248","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107281248?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:36","pubTimestamp":1789115784,"startTime":"0","endTime":"0","summary":"Daiwa has released a research report stating that it has lowered its earnings per share forecasts for HAIDILAO (06862) for the 2026 to 2028 period, reflecting both the lack of demand improvement and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1233","BK1604","BK1591","LU2488822045.USD","EWH","BK1583","BK1589","06862"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199499236","title":"Hansoh Pharma's Investigational Therapy for Small Cell Lung Cancer Granted Priority Review by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199499236","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199499236?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:36","pubTimestamp":1789115780,"startTime":"0","endTime":"0","summary":"Hansoh Pharma (03692) has announced that its investigational drug, Injectable Ruikang Livotamab (HS-20093), has been accepted into the priority review and approval process by China's National Medical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547394","title":"China Resources Beer (Holdings) Stock Slips 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666547394?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:33","pubTimestamp":1789115580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of China Resources Beer  Co. Ltd. shed 1.8% to 18.34 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.6% to 24805.63.This was the stock's third consecutive day of losses.China Resources Beer  Co. Ltd. closed 38% below its 52-week high of HK$29.40, which the company achieved Sept. 12.Trading volume totaled 10.8 million shares, compared to the 50-day average of 12.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00291","IE0008368742.USD","BK1589","IE00BPRC5H50.USD","LU1769817179.HKD","LU1328615791.USD","BK1604","BK1570","BK1510","IE0008369823.USD","LU1794554557.SGD","SG9999006514.SGD","LU0328353924.USD","LU1023057109.AUD","IE00B031HY20.USD","BK1521","LU0359201612.USD","BK1180","LU1769817096.USD","BK1578","LU0359202008.SGD","IE0031814852.USD","CRHKY","IE00B29SXG58.USD","BK1583","80291","LU1720050803.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00B0169L03.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666473975","title":"Haidilao International Holding Stock Rallies 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666473975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666473975?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:33","pubTimestamp":1789115580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Haidilao International Holding Ltd. advanced 1.5% to 10.06 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.6% to 24805.63.The stock's rise snapped a two-day losing streak.Haidilao International Holding Ltd. closed 44% short of its 52-week high of HK$17.86, which the company achieved Feb. 26.Trading volume totaled 52.6 million shares, compared to the 50-day average of 22.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06862","BK1591","LU2488822045.USD","BK1233","BK1583","BK1589","BK1604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547324","title":"Hansoh Pharmaceutical Group Stock Slides 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547324","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666547324?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:32","pubTimestamp":1789115520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slid 1.9% to 32.72 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.6% to 24805.63.This was the stock's fourth consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 26% short of its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 13.2 million shares, compared to the 50-day average of 12.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hansoh Pharmaceutical Group Stock Slides 1.9% in Hong Kong","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666835547","title":"Hansoh Pharma Says NMPA Grants Priority Review for HS-20093 in Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666835547","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666835547?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:31","pubTimestamp":1789115492,"startTime":"0","endTime":"0","summary":"Hansoh Pharma says NMPA grants priority review for HS-20093 in small cell lung cancerHansoh’s HS-20093 (risvutatug rezetecan) for small cell lung cancer entered China NMPA priority review on Aug. 21, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL1SWsdJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666542008","title":"Hansoh Pharmaceutical - Risvutatug Rezetecan for Injection Included in Nmpa Priority Review for Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666542008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666542008?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:31","pubTimestamp":1789115467,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45214K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1589","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188732548","title":"MEDCAPTAIN's Hong Kong IPO: A Medical Device Empire Built on Acquisitions Faces Multiple Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1188732548","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188732548?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:40","pubTimestamp":1789112453,"startTime":"0","endTime":"0","summary":"MEDCAPTAIN has officially launched its global offering on the Hong Kong stock exchange. Originating from a small infusion equipment manufacturer, the company has leveraged capital support and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","RSPH","02041","09996","BK1583","BK4588","MDEV","XMMO","LNGR","MEDX","BK4585","CALF","BK1100","AGNG","IEIH","PTH","LGHT","GDOC","MYLD","HART","159883","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":5,"totalSize":332,"code":"91000000","status":"200"}]}}